Korea Investment CORP Buys 4,900 Shares of Cardinal Health, Inc. (NYSE:CAH)

Korea Investment CORP lifted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 166,127 shares of the company's stock after purchasing an additional 4,900 shares during the quarter. Korea Investment CORP owned about 0.07% of Cardinal Health worth $19,648,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Cyrus J. Lawrence LLC purchased a new position in Cardinal Health during the fourth quarter worth $26,000. Promus Capital LLC bought a new position in shares of Cardinal Health during the fourth quarter valued at approximately $30,000. Lee Danner & Bass Inc. purchased a new position in shares of Cardinal Health in the 4th quarter valued at $35,000. Kentucky Trust Co bought a new position in shares of Cardinal Health during the 4th quarter worth approximately $41,000. Finally, HHM Wealth Advisors LLC grew its stake in Cardinal Health by 57.6% during the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock worth $47,000 after buying an additional 144 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Wells Fargo & Company upped their target price on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Mizuho increased their target price on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday. TD Cowen upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and boosted their price target for the stock from $130.00 to $144.00 in a research report on Wednesday, January 8th. Jefferies Financial Group raised shares of Cardinal Health from a "hold" rating to a "buy" rating and upped their price objective for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Finally, Morgan Stanley lifted their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research report on Friday, January 31st. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and an average target price of $140.14.

Cardinal Health Stock Performance

Shares of CAH stock traded down $0.64 on Thursday, hitting $138.03. The stock had a trading volume of 750,204 shares, compared to its average volume of 2,372,693. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $139.50. The firm has a market capitalization of $33.34 billion, a price-to-earnings ratio of 25.75, a P/E/G ratio of 1.49 and a beta of 0.66. The stock's 50 day moving average is $128.98 and its 200-day moving average is $121.33.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.